title: Human major histocompatibility complex class II-negative colon carcinoma cells present staphylococcal superantigens to cytotoxic T lymphocytes: evidence for a novel enterotoxin receptor.
abstract: The staphylococcal enterotoxins (SE) bind to major histocompatibility complex (MHC) class II molecules on target cells and activate T cells expressing particular T cell receptor V beta sequences. In this report we demonstrate that SE bind to the MHC class II- SW620, Colo320DM and WiDr human colon carcinoma cell lines and direct cytotoxic T lymphocytes (CTL) to mediate strong target cell killing. Flow cytometry analysis, immunoprecipitation and Northern blotting experiments failed to demonstrate any surface expression of HLA-DR, HLA-DP and HLA-DQ isotypes on the SW620 colon carcinoma cell line, whereas abundant expression of these isotypes was seen on Raji cells, SEB and SEC1 were efficiently presented at picomolar concentration by the MHC class II- colon carcinoma cells and MHC class II+ Raji cells, whereas SEA and SED were preferentially presented on the MHC class II+ Raji cells. An anti-HLA-DR monoclonal antibody inhibited SEB-induced CTL targeting to Raji, but did not influence the killing of SW620 cells. Our data suggests the existence of functionally active SE-binding structures on human colon carcinoma cells which are distinct from the conventional MHC class II molecules. The possibility that these putative new SE receptors play a role in the enterotoxin action of SE must be considered.
authors.affiliation: Kabi Pharmacia Therapeutics AB, Ideon Science Park, Malmö, Sweden.
authors.forename: M
authors.initials: M
authors.lastname: Dohlsten
authors.forename: G
authors.initials: G
authors.lastname: Hedlund
authors.forename: S
authors.initials: S
authors.lastname: Segren
authors.forename: P A
authors.initials: PA
authors.lastname: Lando
authors.forename: T
authors.initials: T
authors.lastname: Herrmann
authors.forename: A P
authors.initials: AP
authors.lastname: Kelly
authors.forename: T
authors.initials: T
authors.lastname: Kalland
mesh_terms: D000942:Antigens, Bacterial / Q000276:immunology*; D002277:Carcinoma / Q000276:immunology*; D002460:Cell Line; D003110:Colonic Neoplasms / Q000276:immunology*; D004768:Enterotoxins / Q000378:metabolism / Q000494:pharmacology*; D006162:Guanylate Cyclase; D006684:HLA-DR Antigens / Q000032:analysis; D000949:Histocompatibility Antigens Class II / Q000032:analysis* / Q000502:physiology; D006801:Humans; D011956:Receptors, Cell Surface / Q000502:physiology*; D000074261:Receptors, Enterotoxin; D050705:Receptors, Guanylate Cyclase-Coupled; D018000:Receptors, Peptide; D013211:Staphylococcus aureus / Q000276:immunology*; D013602:T-Lymphocytes, Cytotoxic / Q000187:drug effects* / Q000276:immunology
chemical_list: D000942:Antigens, Bacterial; D004768:Enterotoxins; D006684:HLA-DR Antigens; D000949:Histocompatibility Antigens Class II; D011956:Receptors, Cell Surface; D018000:Receptors, Peptide; D006162:Guanylate Cyclase; D000074261:Receptors, Enterotoxin; D050705:Receptors, Guanylate Cyclase-Coupled